Dizal (Jiangsu) Pharmaceutical Co. Ltd. A (688192 SHG) stock market data APIs

¥41.95 -0.35(-0.8%)
as of February 5, 2025

Dizal (Jiangsu) Pharmaceutical Co. Ltd. A Financial Data Overview

Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases. It develops JAUKPO, which is in Phase II clinical trials for the treatment of hematological malignancy and immunological diseases; DZD8586 that is in Phase I for the treatment of hematological malignancy; ZEGFROVY, which is in Phase II clinical trials for the treatment of solid tumors; DZD1516 that is in Phase II clinical trials for the treatment of solid tumors; and DZD2269, which is in Phase I clinical trials for the treatment of solid tumors. The company was founded in 2017 and is based in Shanghai, China.

Prev. Close 42.64
Open 41.95
High 42.87
Low 41.25
52 wk Range 30.11-51.15
Market Cap 17 667 M
Shares Outstanding 418 M
Revenue 390 M
EPS -0.5869
Beta 0.266

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Dizal (Jiangsu) Pharmaceutical Co. Ltd. A data using free add-ons & libraries


Get Dizal (Jiangsu) Pharmaceutical Co. Ltd. A Fundamental Data

Dizal (Jiangsu) Pharmaceutical Co. Ltd. A Fundamental data includes:

  • Net Revenue: 390 M
  • EBITDA: -924 246 720
  • Earnings Per Share: -2
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Dizal (Jiangsu) Pharmaceutical Co. Ltd. A Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2023-04-28
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Dizal (Jiangsu) Pharmaceutical Co. Ltd. A End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Dizal (Jiangsu) Pharmaceutical Co. Ltd. A News

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat